4.4 Editorial Material

Cancer in myotonic dystrophy: A new discovery in an old disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study

Eleonora S. D'Ambrosio et al.

Summary: This study aimed to compare the frequency and types of cancer in patients with muscular dystrophy. The results showed that DM patients had an increased risk of cancer, with DM1 patients having an increased risk of ovarian cancer and DM2 patients having an increased risk of non-melanoma skin, urological, and hematological cancers.

MUSCLE & NERVE (2023)

Article Medicine, Research & Experimental

Senescence plays a role in myotonic dystrophy type 1 br

Mikel Garcia-Puga et al.

Summary: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by progressive muscular weakness and multisystem degeneration. The accumulation of cellular senescence has been identified as part of the pathophysiology of the disease, and the efficacy of senolytic compounds in reversing accelerated aging phenotypes has been demonstrated in preclinical models.

JCI INSIGHT (2022)

Article Oncology

Altered Expression of MBNL Family of Alternative Splicing Factors in Colorectal Cancer

Nazila Navvabi et al.

Summary: The study identified deregulation of MBNL genes in colorectal cancer for the first time, with down-regulation of their transcripts in tumor tissue compared to non-tumor mucosa. Additionally, lower expression of FOXP1 and EPB41L3 variants was observed, while higher expression was detected for total CD44 and its cancer-related variants 3 and 6 in tumor tissue. Multiple significant associations were found in the target gene panel, including higher transcript levels of FOXP1 and CD44v3 in patients with distant metastases and connections between recurrence-free survival and altered levels of FOXP1 and CD44v3.

CANCER GENOMICS & PROTEOMICS (2021)

Article Oncology

Diabetes, metformin and cancer risk in myotonic dystrophy type I

Rotana Alsaggaf et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Clinical Neurology

Survival patterns and cancer determinants in families with myotonic dystrophy type 1

A. F. Best et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Clinical Neurology

Benign tumors in myotonic dystrophy type I target disease-related cancer sites

Rotana Alsaggaf et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis

Jose I. Emparanza et al.

MUSCLE & NERVE (2018)

Article Oncology

Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity

Rotana Alsaggaf et al.

JNCI CANCER SPECTRUM (2018)

Article Clinical Neurology

Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors

Maria Laura Ester Bianchi et al.

JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation

Roberto Fernandez-Torron et al.

NEUROLOGY (2016)

Article Clinical Neurology

Correlates of tumor development in patients with myotonic dystrophy

Maya Das et al.

JOURNAL OF NEUROLOGY (2012)

Article Medicine, General & Internal

Increased Cancer Risks in Myotonic Dystrophy

Aung Ko Win et al.

MAYO CLINIC PROCEEDINGS (2012)

Article Medicine, General & Internal

Cancer Risk Among Patients With Myotonic Muscular Dystrophy

Shahinaz M. Gadalla et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Review Oncology

Hypothesis: neoplasms in myotonic dystrophy

Christine M. Mueller et al.

CANCER CAUSES & CONTROL (2009)

Review Genetics & Heredity

Myotonic dystrophy: RNA pathogenesis comes into focus

LPW Ranum et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2004)